115 related articles for article (PubMed ID: 32376981)
1. Longitudinal follow-up after telephone disclosure in the randomized COGENT study.
Kilbride MK; Egleston BL; Hall MJ; Patrick-Miller LJ; Daly MB; Ganschow P; Grana G; Olopade OI; Fetzer D; Brandt A; Chambers R; Clark DF; Forman A; Gaber R; Gulden C; Horte J; Long JM; Lucas T; Madaan S; Mattie K; McKenna D; Montgomery S; Nielsen S; Powers J; Rainey K; Rybak C; Savage M; Seelaus C; Stoll J; Stopfer JE; Yao XS; Domchek SM; Bradbury AR
Genet Med; 2020 Aug; 22(8):1401-1406. PubMed ID: 32376981
[TBL] [Abstract][Full Text] [Related]
2. Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results.
Bradbury AR; Patrick-Miller LJ; Egleston BL; Hall MJ; Domchek SM; Daly MB; Ganschow P; Grana G; Olopade OI; Fetzer D; Brandt A; Chambers R; Clark DF; Forman A; Gaber R; Gulden C; Horte J; Long JM; Lucas T; Madaan S; Mattie K; McKenna D; Montgomery S; Nielsen S; Powers J; Rainey K; Rybak C; Savage M; Seelaus C; Stoll J; Stopfer JE; Yao XS
J Natl Cancer Inst; 2018 Sep; 110(9):985-993. PubMed ID: 29490071
[TBL] [Abstract][Full Text] [Related]
3. Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results.
Patrick-Miller L; Egleston BL; Daly M; Stevens E; Fetzer D; Forman A; Bealin L; Rybak C; Peterson C; Corbman M; Bradbury AR
Patient Educ Couns; 2013 Dec; 93(3):413-9. PubMed ID: 24075727
[TBL] [Abstract][Full Text] [Related]
4. Preferences for in-person disclosure: Patients declining telephone disclosure characteristics and outcomes in the multicenter Communication Of GENetic Test Results by Telephone study.
Beri N; Patrick-Miller LJ; Egleston BL; Hall MJ; Domchek SM; Daly MB; Ganschow P; Grana G; Olopade OI; Fetzer D; Brandt A; Chambers R; Clark DF; Forman A; Gaber R; Gulden C; Horte J; Long J; Lucas T; Madaan S; Mattie K; McKenna D; Montgomery S; Nielsen S; Powers J; Rainey K; Rybak C; Savage M; Seelaus C; Stoll J; Stopfer JE; Yao XS; Bradbury AR
Clin Genet; 2019 Feb; 95(2):293-301. PubMed ID: 30417332
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of mailed results versus telephone disclosure of normal cancer genetic test results in a low-risk underserved population.
Gilmore MJ; Leo MC; Amendola LM; Goddard KAB; Ezzell Hunter J; Joseph G; Kauffman TL; Rolf B; Shuster E; Zepp JM; Wilfond BS; Biesecker BB
Transl Behav Med; 2024 Jun; 14(7):377-385. PubMed ID: 38190737
[TBL] [Abstract][Full Text] [Related]
6. Retrospective comparison of patient outcomes after in-person and telephone results disclosure counseling for BRCA1/2 genetic testing.
Doughty Rice C; Ruschman JG; Martin LJ; Manders JB; Miller E
Fam Cancer; 2010 Jun; 9(2):203-12. PubMed ID: 20473602
[TBL] [Abstract][Full Text] [Related]
7. Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results.
Bradbury AR; Patrick-Miller L; Fetzer D; Egleston B; Cummings SA; Forman A; Bealin L; Peterson C; Corbman M; O'Connell J; Daly MB
Clin Genet; 2011 Feb; 79(2):125-31. PubMed ID: 21039431
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone.
Christensen KD; Uhlmann WR; Roberts JS; Linnenbringer E; Whitehouse PJ; Royal CDM; Obisesan TO; Cupples LA; Butson MB; Fasaye GA; Hiraki S; Chen CA; Siebert U; Cook-Deegan R; Green RC
Genet Med; 2018 Jan; 20(1):132-141. PubMed ID: 28726810
[TBL] [Abstract][Full Text] [Related]
9. MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.
Rayes N; Bowen DJ; Coffin T; Nebgen D; Peterson C; Munsell MF; Gavin K; Lechner R; Crase J; Polinsky D; Romero I; Blank SV; Levine DA; Norquist BM; Swisher EM; Lu KH
BMC Cancer; 2019 Jul; 19(1):648. PubMed ID: 31266460
[TBL] [Abstract][Full Text] [Related]
10. Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling.
Jenkins J; Calzone KA; Dimond E; Liewehr DJ; Steinberg SM; Jourkiv O; Klein P; Soballe PW; Prindiville SA; Kirsch IR
Genet Med; 2007 Aug; 9(8):487-95. PubMed ID: 17700386
[TBL] [Abstract][Full Text] [Related]
11. Telephone versus in-person genetic counseling for hereditary cancer risk: Patient predictors of differential outcomes.
Binion S; Sorgen LJ; Peshkin BN; Valdimarsdottir H; Isaacs C; Nusbaum R; Graves KD; DeMarco T; Wood M; McKinnon W; Garber J; McCormick S; Ladd MK; Schwartz MD
J Telemed Telecare; 2024 Feb; 30(2):334-343. PubMed ID: 34779303
[TBL] [Abstract][Full Text] [Related]
12. Ethical, legal, and social implications (ELSI) and challenges in the design of a randomized controlled trial to test the online return of cancer genetic research results to U.S. Black women.
Wang C; Bertrand KA; Trevino-Talbot M; Flynn M; Ruderman M; Cabral HJ; Bowen DJ; Hughes-Halbert C; Palmer JR
Contemp Clin Trials; 2023 Sep; 132():107309. PubMed ID: 37516165
[TBL] [Abstract][Full Text] [Related]
13. Considerations for the Telephone Disclosure of Genetic Test Results to Patients With Cancer.
Mahon SM
Clin J Oncol Nurs; 2020 Feb; 24(1):8. PubMed ID: 31961845
[TBL] [Abstract][Full Text] [Related]
14. Patient satisfaction of BRCA1/2 genetic testing by women at high risk for breast cancer participating in a prevention trial.
Klemp JR; O'Dea A; Chamberlain C; Fabian CJ
Fam Cancer; 2005; 4(4):279-84. PubMed ID: 16341803
[TBL] [Abstract][Full Text] [Related]
15. Prenatal patient perceptions of receiving difficult news over the telephone.
Douglas TC; May C; Dent K; Carey JC; Mladucky J
J Genet Couns; 2023 Aug; 32(4):857-869. PubMed ID: 36843230
[TBL] [Abstract][Full Text] [Related]
16. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
17. Randomized study of remote telehealth genetic services versus usual care in oncology practices without genetic counselors.
Cacioppo CN; Egleston BL; Fetzer D; Burke Sands C; Raza SA; Reddy Malleda N; McCarty Wood E; Rittenburg I; Childs J; Cho D; Hosford M; Khair T; Khatri J; Komarnicky L; Poretta T; Rahman F; Shah S; Patrick-Miller LJ; Domchek SM; Bradbury AR
Cancer Med; 2021 Jul; 10(13):4532-4541. PubMed ID: 34102012
[TBL] [Abstract][Full Text] [Related]
18. Research participants' experiences with return of genetic research results and preferences for web-based alternatives.
Gaieski JB; Patrick-Miller L; Egleston BL; Maxwell KN; Walser S; DiGiovanni L; Brower J; Fetzer D; Ganzak A; McKenna D; Long JM; Powers J; Stopfer JE; Nathanson KL; Domchek SM; Bradbury AR
Mol Genet Genomic Med; 2019 Sep; 7(9):e898. PubMed ID: 31376244
[TBL] [Abstract][Full Text] [Related]
19. Development of a communication protocol for telephone disclosure of genetic test results for cancer predisposition.
Patrick-Miller LJ; Egleston BL; Fetzer D; Forman A; Bealin L; Rybak C; Peterson C; Corbman M; Albarracin J; Stevens E; Daly MB; Bradbury AR
JMIR Res Protoc; 2014 Oct; 3(4):e49. PubMed ID: 25355401
[TBL] [Abstract][Full Text] [Related]
20. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
Schwartz MD; Valdimarsdottir HB; Peshkin BN; Mandelblatt J; Nusbaum R; Huang AT; Chang Y; Graves K; Isaacs C; Wood M; McKinnon W; Garber J; McCormick S; Kinney AY; Luta G; Kelleher S; Leventhal KG; Vegella P; Tong A; King L
J Clin Oncol; 2014 Mar; 32(7):618-26. PubMed ID: 24449235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
